Tag Archives: David Baker

Company founded by two Marquette University researchers raises $26 million in funding

News release, April 10, 2017

Promentis Pharmaceuticals, a Milwaukee company co-founded by Drs. John Mantsch and David Baker, researchers from the Marquette University College of Health Sciences, raised $26 million, including $17.2 million in its third funding round. OrbiMed, F-Prime Capital Partners (formerly Fidelity Biosciences) and Aisling Capital were the lead investors. This is exceptional syndicate of investors, particularly for […]

Continue...

Marquette researchers receive $1.85 million grant for neuroscience study

News release, September 11, 2014

Research will examine novel mechanism contributing to addiction A group of neuroscientists in the College of Health Sciences at Marquette University has been awarded a $1.85 million National Institutes of Health grant to examine a novel neurotransmitter clearance mechanism that may hold a key to understanding the link between stress and drug addiction, as well […]

Continue...

Marquette biomedical sciences professor receives Way Klingler Fellowship in science

News release, August 16, 2013

Dr. David Baker, professor and associate chair of the Department of Biomedical Sciences in the College of Health Sciences at Marquette University, has been awarded the 2013 Way Klingler Fellowship in science for his study of neurotransmitters and their roles in diseases like schizophrenia and addiction. Baker will receive $50,000 annually for three years for […]

Continue...